3-((ACETYLOXY)METHYLENE)-1,3-DIHYDRO-4-(4-METHYL-1-PIPERAZINYL)-2H-1,5-BENZODIAZEPINE-2-THIONE, (3Z)-
UNII R3XSK9P9JT
Substance Identification & Data
This profile provides standardized clinical and technical data for 3-((acetyloxy)methylene)-1,3-dihydro-4-(4-methyl-1-piperazinyl)-2h-1,5-benzodiazepine-2-thione, (3z)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) R3XSK9P9JT.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1320360-87-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C17H20N4O2S KMCOFWWWTNQXFV-QBFSEMIESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 3-((acetyloxy)methylene)-1,3-dihydro-4-(4-methyl-1-piperazinyl)-2h-1,5-benzodiazepine-2-thione, (3z)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.